Skip to main content
Clinical Trials/NCT05892822
NCT05892822
Not yet recruiting
Not Applicable

Amyotrophic Lateral Sclerosis Registry

yilong Wang1 site in 1 country1,000 target enrollmentJune 15, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Amyotrophic Lateral Sclerosis
Sponsor
yilong Wang
Enrollment
1000
Locations
1
Primary Endpoint
Gene Mutation Characteristics of ALS in Chinese
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

This study takes amyotrophic lateral sclerosis (ALS) patients as the main research object. Through collecting genetics, imaging and clinical symptoms for Exploratory research, we will construct the gene spectrum of ALS in China, explore unknown pathogenic genes, explore the characteristic image characteristics of ALS, and establish the iPSCs library of ALS, providing resources and basis for the research of pathogenesis and treatment targets of ALS.

Detailed Description

This study is a multicenter, prospective registration study that will follow up patients with clinically confirmed and suspected amyotrophic lateral sclerosis for a period of 2 years. A total of 1000 patients will be included to dynamically observe the changes in clinical symptoms and signs, imaging, electrophysiology, biomarkers, biological samples and so on, which will construct a genetic profile of ALS in China, explore the etiology and pathogenesis, and establish an iPSCs library, provide a basis for finding treatment targets.

Registry
clinicaltrials.gov
Start Date
June 15, 2023
End Date
December 31, 2024
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
yilong Wang
Responsible Party
Sponsor Investigator
Principal Investigator

yilong Wang

Vice-President of Beijing Tiantan Hospital,Chief Scientist of Neurology Center

Beijing Tiantan Hospital

Eligibility Criteria

Inclusion Criteria

  • 18 years old ≤ age ≤ 80 years old;
  • Patients are diagnosed definite or probable ALS according to the Awaji diagnostic criteria;
  • Sign an informed consent form.

Exclusion Criteria

  • Unable to cooperate with research or complete follow-up due to geographical or other reasons.

Outcomes

Primary Outcomes

Gene Mutation Characteristics of ALS in Chinese

Time Frame: day 1

Constructing a Chinese ALS genetic information database by collecting genetic information from patients.

The disease development of ALS in the Chinese

Time Frame: month 24

Record the progress of patients' clinical symptoms from baseline through 2-year follow-up.

Secondary Outcomes

  • Exploring the imaging characteristics of ALS in the Chinese(day 1, month 3, month 6, month 9, month 12, month 15, month 18, month 21, month 24)
  • Establishing an iPSCs library for ALS in the Chinese(day 1)
  • Analysis of the correlation between electrophysiology characteristics and imaging characteristics of ALS in Chinese(day 1, month 3, month 6, month 9, month 12, month 15, month 18, month 21, month 24)

Study Sites (1)

Loading locations...

Similar Trials